[Sodium-hypertension and diuretics].
作者信息
Naess K
出版信息
Tidsskr Nor Laegeforen. 1971 Jan 10;91(1):34.
PMID:5538883
Abstract
摘要
相似文献
1
[Sodium-hypertension and diuretics].
Tidsskr Nor Laegeforen. 1971 Jan 10;91(1):34.
2
Moderate sodium restriction and various diuretics in the treatment of hypertension.
Arch Intern Med. 1981 Jul;141(8):1015-9.
3
Pathophysiology of antihypertensive therapy with diuretics.
Hypertens Res. 2006 Sep;29(9):645-53. doi: 10.1291/hypres.29.645.
4
[Reinstatement of sodium restriction and diuretics in the treatment of hypertension].
Ned Tijdschr Geneeskd. 1996 Dec 28;140(52):2610-4.
5
[The diuretics].
Soins. 1986 May(477-478):4.
6
[Salidiuresis in the treatment of arterial hypertension].
Cah Coll Med Hop Paris. 1967 Jun 15;8(7):592-4.
7
The use of diuretics in hypertension.
Aust Fam Physician. 1982 Aug;11(8):609-10, 612-3.
8
[Saluresis in the treatment of hypertension].
Munch Med Wochenschr. 1966 Dec 23;108(51):2579-81.
9
[Hypertension, sodium withdrawal and saluretics].
Med Welt. 1969 Mar 29;13:736-8.
10
[Saluretics and hypertension].
Clin Ter. 1969 Oct;51(1):3-14.
引用本文的文献
1
Exosome-related Methods and Potential Use as Vaccines.
Methods Mol Biol. 2022;2435:35-41. doi: 10.1007/978-1-0716-2014-4_4.
2
EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
Cancer Chemother Pharmacol. 2021 Dec;88(6):1021-1031. doi: 10.1007/s00280-021-04348-5. Epub 2021 Oct 2.
3
The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.
Pharmacol Res. 2021 Aug;170:105692. doi: 10.1016/j.phrs.2021.105692. Epub 2021 Jun 25.
4
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking.
Exp Mol Med. 2019 Mar 15;51(3):1-12. doi: 10.1038/s12276-019-0223-5.
Zotero 插件